Article Details

NeoGenomics to acquire Inivata for $390M after success of lung cancer liquid biopsy collab

Retrieved on: 2021-05-06 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

NeoGenomics to acquire Inivata for $390M after success of lung cancer liquid biopsy collab. View article details on hiswai:

Excerpt

The Florida-based company will also direct its existing biopharma-focused sales team and a future group of genomic sequencing-focused ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up